Article
iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine
25 Jun 2024
Abstract excerpt
This year marks the tenth anniversary of the world's first transplantation of tissue generated from induced pluripotent stem cells (iPSCs). There is now a growing number of clinical trials worldwide examining the efficacy and safety of autologous and allogeneic iPSC-derived products for treating various pathologic conditions. As we patiently wait for the results from these and future clinical trials, it is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
